These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7129679)

  • 1. Armed human monocytes challenged with a sensitizing cancer extract release substances pharmacologically similar to leukotrienes.
    Thomson DM; Phelan K; Morton DG; Bach MK
    Int J Cancer; 1982 Sep; 30(3):299-306. PubMed ID: 7129679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotrienes (LTC4, LTD4) confer glass non-adherence on leukocytes of asthmatic individuals. Dependency on cyclooxygenase products and calcium ion.
    Fink A; Bibi H; Eliraz A; Tabachnik E; Bentwich Z
    Immunol Lett; 1985; 10(6):319-23. PubMed ID: 3930397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative metabolism, cytoskeletal system, and calcium entry of leukocytes in the phenomenon of sensitizing cancer extract-induced leukocyte adherence inhibition.
    Thomson DM; Phelan K; Scanzano R
    Cancer Res; 1983 Mar; 43(3):1066-73. PubMed ID: 6681728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of antigen-induced leukocyte adherence inhibition by metabolites of arachidonic acid and intracellular nucleotides.
    Thomson DM; Phelan K; Scanzano R; Fink A
    Int J Cancer; 1982 Sep; 30(3):311-9. PubMed ID: 6752047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
    Shenouda G; Thomson DM; MacFarlane JK
    Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte adherence inhibition to myelin basic protein by cancer patients' T-lymphocytes in association with class II major histocompatibility antigens on monocytes.
    Thomson DM; Halliday WJ; Phelan K
    J Natl Cancer Inst; 1985 Dec; 75(6):995-1003. PubMed ID: 2415744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte activation in advanced cancer as an explanation for absent leukocyte adherence inhibition to cancer extracts and chemoattractant.
    Labateya N; Thomson DM; Reid EC
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):33-43. PubMed ID: 3007156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen-specific leukocyte adherence inhibition (LAI) assay: sensitivity, specificity and mechanism.
    Fink A; Heller L; Eliraz A; Weisman Z; Miskin A; Schlezinger M; Bibi H; Bentwich Z
    Immunol Lett; 1987 Oct; 16(1):65-70. PubMed ID: 3323035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigens.
    Thomson DM; Springer GF; Desai PR; Scanzano R; Gubersky M; Shenouda G
    Clin Immunol Immunopathol; 1988 Nov; 49(2):231-41. PubMed ID: 2458874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. "Blockade" of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients.
    Grosser N; Thompson DM
    Int J Cancer; 1976 Jul; 18(1):58-66. PubMed ID: 59711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence in advanced cancer of an activated leukocyte state to explain the reversible defect in transmembrane signaling and leukocyte adherence inhibition to extracts of cancer.
    Shenouda G; Thomson DM
    Clin Immunol Immunopathol; 1984 Aug; 32(2):212-23. PubMed ID: 6375921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible abnormal nonadherence to glass and responsiveness to chemoattractants of leukocytes from patients with advanced cancer.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):607-16. PubMed ID: 6088879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE.
    Ferreri NR; Howland WC; Spiegelberg HL
    J Immunol; 1986 Jun; 136(11):4188-93. PubMed ID: 3009617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibody.
    Marti JH; Grosser N; Thomson DM
    Int J Cancer; 1976 Jul; 18(1):48-57. PubMed ID: 947860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane signal defect and absence of cancer extract induced leukocyte adherence inhibition (LAI) for leukocytes from patients with advanced cancer.
    Shenouda G; Thomson DM
    Cancer Immunol Immunother; 1984; 18(1):59-68. PubMed ID: 6333270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon modulates the leukotriene C4-induced non-adherence properties of leukocytes: acquisition of an asthmatic phenotype.
    Fink A; Shahin R; Eliraz A; Bibi H; Berkenstadt H; Levin S; Bentwich Z
    Immunol Lett; 1985; 10(3-4):159-63. PubMed ID: 2995245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophages.
    Ichiyama T; Hasegawa M; Ueno Y; Makata H; Matsubara T; Furukawa S
    Clin Exp Allergy; 2005 Sep; 35(9):1214-9. PubMed ID: 16164450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial characterization of the soluble mediator of leukocyte adherence inhibition.
    Appelboom T; Pierart M; Ameryckx G; Mairesse N
    J Rheumatol; 1987 Jun; 14(3):420-5. PubMed ID: 3498031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.